Structure-activity relationship of synthetic variants of the milk-derived antimicrobial peptide αs2-casein f(183-207)

Applied and Environmental Microbiology

Volumn 79, Issue 17, 2013, Pages 5179-5185

  Alvarez Ordóñez, Avelino ^a   Begley, Máire ^a   Clifford, Tanya ^a   Deasy, Thérése ^a   Considine, Kiera ^a   Hill, Colin ^a,b  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID SEQUENCE; ANTI-BACTERIAL ACTIVITY; ANTIMICROBIAL PEPTIDE; BACTERICIDAL ACTIVITY; FOOD-BORNE PATHOGENS; LISTERIA MONOCYTOGENES; POSITIVELY CHARGED; STRUCTURE ACTIVITY RELATIONSHIPS;

AMINO ACIDS; BIOACTIVITY; CASEIN; PATHOGENS; POLYPEPTIDES;

PEPTIDES;

AMINO ACID; ANTIMICROBIAL ACTIVITY; FOOD QUALITY; FOOD SECURITY; GENE EXPRESSION; HYDROPHOBICITY; MILK; PATHOGEN; PEPTIDE; SALINITY;

EID: 84884277897     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.01394-13     Document Type: Article

References (40)

1. Hartmann R, Meisel H. 2007. Food-derived peptides with biological activity: from research to food applications. Curr. Opin. Biotechnol. 18: 163-169.
2. Li Y, Xiang Q, Zhang Q, Huang Y, Su Z. 2012. Overview on the recent study of antimicrobial peptides: origins, functions, relative mechanisms and application. Peptides 37:207-215.
3. Mills S, Ross RP, Hill C, Fitzgerald GF, Stanton C. 2011. Milk intelligence: mining milk for bioactive substances associated with human health. Int. Dairy J. 21:377-401.
4. Hayes A, Ross RP, Fitzgerald GF, Hill C, Stanton C. 2006. Caseinderived antimicrobial peptides generated by Lactobacillus acidophilus DPC6026. Appl. Environ. Microbiol. 72:2260-2264.
5. Malkoski M, Dashper SG, O'Brien-Simpson NM, Talbo GH, Macris M, Cross KJ, Reynolds EC. 2001. Kappacin, a novel antibacterial peptide from bovine milk. Antimicrob. Agents Chemother. 45:2309-2315.
6. Lahov E, Regelson W. 1996. Antibacterial and immunostimulating casein- derived substances from milk: casecidin, isracidin peptides. Food Chem. Toxicol. 34:131-145.
7. Bellamy W, Takase M, Wakabayashi H, Kawase K, Tomita M. 1992. Antibacterial spectrum of lactoferricin B, a potent bactericidal peptide derived from the N-terminal region of bovine lactoferrin. J. Appl. Bacteriol. 73:472-479.
8. s2 derived peptide exhibits antibacterial activity. FEBS Lett. 372:185-188.
9. s2-casein. Biochim. Biophys. Acta 1428:314-326.
10. s2-casein f(183-207) and effect on bacterial membranes and cell morphology. Biochim. Biophys. Acta 1778:2444-2449.
11. Shai Y. 1999. Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by alpha-helical antimicrobial and cell non-selective membrane-lytic peptides. Biochim. Biophys. Acta 1462:55-70.
12. Fjell CD, Hiss JA, Hancock RE, Schneider G. 2012. Designing antimicrobial peptides: form follows function. Nat. Rev. Drug Discov. 11:37-51.
13. Haversen L, Kondori N, Baltzer L, Hanson A, Dolphin GT, Dunér K, Mattsby-Baltzer I. 2010. Structure-microbicidal activity relationship of synthetic fragments derived from the antibacterial -helix of human lactoferrin. Antimicrob. Agents Chemother. 54:418-425.
14. Norberg S, O'Connor PM, Stanton C, Ross RP, Hill C, Fitzgerald GF, Cotter PD. 2011. Altering the composition of caseicins A and B as a means of determining the contribution of specific residues to antimicrobial activity. Appl. Environ. Microbiol. 77:2496-2501.
15. Norberg S, O'Connor PM, Stanton C, Ross RP, Hill C, Fitzgerald GF, Cotter PD. 2012. Extensive manipulation of caseicins A and B highlights the tolerance of these antimicrobial peptides to change. Appl. Environ. Microbiol. 78:2353-2358.
16. Schneider G, Schuchhardt J, Wrede P. 1994. Artificial neural networks and simulated molecular evolution are potential tools for sequenceoriented protein design. Comput. Appl. Biosci. 10:635-645.
17. Norberg S, Stanton C, Ross RP, Hill C, Fitzgerald GF, Cotter PD. 2012. Cronobacter spp. in powdered infant formula. J. Food Prot. 75:607-620. 18. Farber JM. 2004. Enterobacter sakazakii-new foods for thought? Lancet 363:5-6.
18. Farber JM. 2004. Enterobacter sakazakii-new foods for thought? Lancet 363:5-6
19. Friedemann M. 2007. Enterobacter sakazakii in food and beverages (other than infant formula and milk powder). Int. J. Food Microbiol. 116:1-10.
20. Beuchat LR, Kim H, Gurtler JB, Lin LC, Ryu JH, Richards GM. 2009. Cronobacter sakazakii in foods and factors affecting its survival, growth and inactivation. Int. J. Food Microbiol. 136:204-213.
21. Osaili T, Forsythe S. 2009. Desiccation resistance and persistence of Cronobacter species in infant formula. Int. J. Food Microbiol. 136:214- 220.
22. Warriner K, Namvar A. 2009. What is the hysteria with Listeria? Trends Food Sci. Tech. 20:245-254.
23. Romestand B, Molina F, Richard V, Roch P, Granier C. 2003. Key role of the loop connecting the two beta strands of mussel defensin in its antimicrobial activity. Eur. J. Biochem. 270:2805-2813.
24. Chen Y, Guarnieri MT, Vasil AI, Vasil ML, Mant CT, Hodges RS. 2007. Role of peptide hydrophobicity in the mechanism of action of alphahelical antimicrobial peptides. Antimicrob. Agents Chemother. 51:1398- 1406.
25. Nan YH, Park KH, Park Y, Jeon YJ, Kim Y, Park IS, Hahm KS, Shin SY. 2009. Investigating the effects of positive charge and hydrophobicity on the cell selectivity, mechanism of action and anti-inflammatory activity of a Trp-rich antimicrobial peptide indolicidin. FEMS Microbiol. Lett. 292: 134-140.
26. Leptihn S, Har JY, Wohland T, Ding JL. 2010. Correlation of charge, hydrophobicity and structure with antimicrobial activity of S1 and MIRIAM peptides. Biochemistry 49:9161-9170.
27. Paulsen VS, Blencke HM, Benincasa M, Hauq T, Eksteen JJ, Styrvold OB, Scocchi M, Stensvag K. 2013. Structure-activity relationships of the antimicrobial peptide arasin1-and mode of action studies of the N-terminal, proline-rich region. PLoS One 8:e53326. doi:10.1371/journal.pone .0053326.
28. Zhang L, Benz R, Hancock REW. 1999. Influence of proline residues on the antibacterial and synergistic activities of alpha-helical peptides. Biochemistry 38:8102-8111.
29. Malmsten M, Kasetty G, Pasupuleti M, Alenfall J, Schmidtchen A. 2011. Highly selective end-tagged antimicrobial peptides derived from PRELP. PLoS One 6:e16400. doi:10.1371/journal.pone.0016400.
30. Schmidtchen A, Pasupuleti M, Morgelin M, Davoudi M, Alenfall J, Chalupka A, Malmsten M. 2009. Boosting antimicrobial peptides by hydrophobic oligopeptide end tags. J. Biol. Chem. 284:17584-17594.
31. Deslousches B, Phadke SM, Lazarevic V, Cascio M, Islam K, Montelaro RC, Mietzner TA. 2005. De novo generation of cationic antimicrobial peptides: influence of length and tryptophan substitution on antimicrobial activity. Antimicrob. Agents Chemother. 49:316-322.
32. Stromstedt AA, Pasupuleti M, Schmidtchen A, Malmsten M. 2009. Evaluation of strategies for improving proteolytic resistance of antimicrobial peptides by using variants of EFK17, an internal segment of LL-37. Antimicrob. Agents Chemother. 53:593-602.
33. Rydlo T, Rotem S, Mor A. 2006. Antibacterial properties of dermaseptin S4 derivatives under extreme incubation conditions. Antimicrob. Agents Chemother. 50:490-497.
34. Vogt TC, Bechinger B. 1999. The interactions of histidine-containing amphipathic helical peptide antibiotics with lipid bilayers. The effects of charges and pH. J. Biol. Chem. 274:29115-29121.
35. Annamalai T, Venkitanarayanan KS, Hoagland TA, Khan MI. 2001. Inactivation of Escherichia coli O157:H7 and Listeria monocytogenes by PR-26, a synthetic antibacterial peptide. J. Food Prot. 64:1929-1934.
36. Maisnier-Patin S, Forni E, Richard J. 1996. Purification, partial characterisation and mode of action of enterococcin EFS2, an antilisterial bacteriocin produced by a strain of Enterococcus faecalis isolated from a cheese. Int. J. Food Microbiol. 30:255-270.
37. Goldman MJ, Anderson GM, Stolzenberg ED, Kari UP, Zasloff M, Wilson JM. 1997. Human beta-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis. Cell 88:553-560.
38. Hancock REW, Lehrer RI. 1998. Cationic peptides: a new source of antibiotics. Trends Biotechnol. 16:82-88.
39. Appendini P, Hotchkiss JH. 1999. Antimicrobial activity of a 14-residue peptide against Escherichia coli O157:H7. J. Appl. Microbiol. 87:750-756.
40. Yaron S, Rydlo T, Shachar D, Mor A. 2003. Activity of dermaseptin K4-S4 against foodborne pathogens. Peptides 24:1815-1821.